VBU Ship is sinking

Quote
























KS, please keep clearing out the dead weight. The division got too fat and lazy and it’s been long overdue that we trim down. The strategy to manage out the underperforming is working. I think we will get where we need to be by late fall.
 






anonymous said:
KS, please keep clearing out the dead weight. The division got too fat and lazy and it’s been long overdue that we trim down. The strategy to manage out the underperforming is working. I think we will get where we need to be by late fall.
Click to expand...

kim, posting here on cafe pharma on what a great job you are doing is another one of your brilliant ideas
 






anonymous said:
kim, posting here on cafe pharma on what a great job you are doing is another one of your brilliant ideas
Click to expand...

kim probably doesn’t even know what cafepharma is! My point is that Al was a nice guy, but change should have happened long ago. This division got too big and he never wanted to shrink it back down where it needed to be. I also always questioned why he hired so many unqualified female Field VP’s. He leaned too far down the diversity trail and got in the weeds. There’s more to diversity than male vs female.
 






anonymous said:
kim probably doesn’t even know what cafepharma is! My point is that Al was a nice guy, but change should have happened long ago. This division got too big and he never wanted to shrink it back down where it needed to be. I also always questioned why he hired so many unqualified female Field VP’s. He leaned too far down the diversity trail and got in the weeds. There’s more to diversity than male vs female.
Click to expand...
Did this stuff come from Al, or Judy? Or even someone else? There is literally no training for these FLL, other then which bathroom they use. So much incompetence.
 


















Shingrix will drive the business unit.
the rest of the portfolio will support the growth to support the #1 vaccine producer in the world.
Most outsiders would give their right arm to work for this marveled unit.
Cry babies, stop your crying. Get on board and lets grow.
 






anonymous said:
Shingrix will drive the business unit.
the rest of the portfolio will support the growth to support the #1 vaccine producer in the world.
Most outsiders would give their right arm to work for this marveled unit.
Cry babies, stop your crying. Get on board and lets grow.
Click to expand...

#1 vaccine producer in the world? Hahah. Not for much longer pediarix, infanrix, and kinrix are obsolete. That’s a third of the ped portfolio. Moderna is ahead of us for RSV, Pfizer is ahead for ABCWY. Shingrix will keep the Vbu Alive, but won’t keep everyone employed. We couldn’t even make a covid vaccine with the monetary vaccine of the government
 






anonymous said:
#1 vaccine producer in the world? Hahah. Not for much longer pediarix, infanrix, and kinrix are obsolete. That’s a third of the ped portfolio. Moderna is ahead of us for RSV, Pfizer is ahead for ABCWY. Shingrix will keep the Vbu Alive, but won’t keep everyone employed. We couldn’t even make a covid vaccine with the monetary vaccine of the government
Click to expand...
Spot on.
 


















anonymous said:
My FLL said GSK has a strategic plan to deal with the competition and I should not worry. I am new with 1 year in the VBU and 4 years post college. I know it might be obvious, what might you all say?
Click to expand...
Now would be a good time to start looking. You will get a nice pay increase at a new company. They have no loyalty to you.
There is no ‘plan’ other then wait and watch the VBU die. The company split next year will make it very easy to spin parts off.
 






























Top Bottom
Back
Quote